India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported to 150 countries. Presently there are 10,500 manufacturing units and over 3,000 pharma companies in India, growing at an exceptional rate.
According to India Ratings, a Fitch company, the Indian pharmaceutical industry is estimated to grow at 20 per cent compound annual growth rate (CAGR) over the next five years. Presently the market size of the pharmaceutical industry in India stands at US$ 20 billion. We all know that the pharmaceutical drug manufacturer use raw material in their formulation process & they are dependent on pharmaceutical raw material supplier, hence pharmaceutical raw material sector will be growing sector.

REXLER is leader in manufacturing world-class excipients and in partnering with leading pharmaceutical companies to improve their own product performance. We are also engaged in exports of a wide range of pharmaceutical raw materials and chemicals to various countries across the globe. All our products are manufactured under strict GMP-ISO compliance. We have adopted latest technology and follow GMP and FDA regulations while manufacturing our products. We manufacture & export our range of products at par with IP/USP/BP/EP/JP standards.